Use of oral anticoagulants in patients with valvular atrial fibrillation: findings from the NCDR PINNACLE Registry

Paul L. Hess, Kensey L. Gosch, Sandeep M. Jani, Paul D. Varosy, Steven M. Bradley, Thomas M. Maddox, P. Michael Ho, Salim S. Virani

Research output: Contribution to journalLetterpeer-review

Abstract

Recent data suggest direct oral anticoagulants are as safe and efficacious as warfarin among select patients with valvular heart disease and atrial fibrillation (AF). However, real-world treatment patterns of AF stroke prophylaxis in the setting of valvular AF are currently unknown. Accordingly, using the prospective, ambulatory National Cardiovascular Data Registry Practice Innovation and Clinical Excellence (PINNACLE) Registry, we sought to characterize overall use, temporal trends in use, and the extent of practice-level variation in the use of any direct oral anticoagulant and warfarin among patients with valvular AF from January 1, 2013, to March 31, 2019.

Original languageEnglish
Pages (from-to)58-62
Number of pages5
JournalAmerican heart journal
Volume240
DOIs
StatePublished - Oct 2021

Fingerprint

Dive into the research topics of 'Use of oral anticoagulants in patients with valvular atrial fibrillation: findings from the NCDR PINNACLE Registry'. Together they form a unique fingerprint.

Cite this